Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Glycerol Monoricinoleate
2. Glyceryl Ricinoleate
3. 1323-38-2
4. Zue0cel42o
5. 1-glyceryl Ricinoleate
6. 141-08-2
7. Unii-zue0cel42o
8. 9-octadecenoic Acid, 12-hydroxy-, (r-(z))-, Monoester With 1,2,3-propanetriol
9. Einecs 215-353-8
10. Ai3-00967
11. Dsstox_cid_22007
12. Dsstox_rid_79901
13. Dsstox_gsid_42007
14. Schembl15687
15. (r)-12-hydroxyoleic Acid, Monoester With Glycerol
16. 9-octadecenoic Acid, 12-hydroxy-, 2,3-dihydroxypropyl Ester, (9z,12r)-
17. Chembl3186157
18. 2,3-dihydroxypropyl (z,12r)-12-hydroxyoctadec-9-enoate
19. Dtxsid90274071
20. Glyceryl 1-monoricinoleate
21. Glyceryl Ricinoleate [ii]
22. Chebi:189184
23. Glyceryl Ricinoleate [inci]
24. Tox21_301962
25. Glyceryl Ricinoleate [who-dd]
26. 9-octadecenoic Acid, 12-hydroxy-, (9z,12r)-, Monoester With 1,2,3-propanetriol
27. 9-octadecenoic Acid, 12-hydroxy-, Monoester With 1,2,3-propanetriol, (r-(z))-
28. Ncgc00255748-01
29. Cas-1323-38-2
30. Q27295893
31. 9-octadecenoic Acid, 12-hydroxy-, (theta-(z))-, Monoester With 1,2,3-propanetriol
Molecular Weight | 372.5 g/mol |
---|---|
Molecular Formula | C21H40O5 |
XLogP3 | 4.8 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 19 |
Exact Mass | 372.28757437 g/mol |
Monoisotopic Mass | 372.28757437 g/mol |
Topological Polar Surface Area | 87 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 343 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Glyceryl Monoricinoleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glyceryl Monoricinoleate, including repackagers and relabelers. The FDA regulates Glyceryl Monoricinoleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glyceryl Monoricinoleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Glyceryl Monoricinoleate supplier is an individual or a company that provides Glyceryl Monoricinoleate active pharmaceutical ingredient (API) or Glyceryl Monoricinoleate finished formulations upon request. The Glyceryl Monoricinoleate suppliers may include Glyceryl Monoricinoleate API manufacturers, exporters, distributors and traders.
Glyceryl Monoricinoleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glyceryl Monoricinoleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glyceryl Monoricinoleate GMP manufacturer or Glyceryl Monoricinoleate GMP API supplier for your needs.
A Glyceryl Monoricinoleate CoA (Certificate of Analysis) is a formal document that attests to Glyceryl Monoricinoleate's compliance with Glyceryl Monoricinoleate specifications and serves as a tool for batch-level quality control.
Glyceryl Monoricinoleate CoA mostly includes findings from lab analyses of a specific batch. For each Glyceryl Monoricinoleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glyceryl Monoricinoleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Glyceryl Monoricinoleate EP), Glyceryl Monoricinoleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glyceryl Monoricinoleate USP).
LOOKING FOR A SUPPLIER?